Biography

Alistair Simpson (Born 1969, British citizen) was appointed Group Vice President Cochlear Implants in July 2024.

Alistair Simpson is responsible for Sonova’s global Cochlear Implants business, including strategy, portfolio development and commercial execution across markets. He has held senior general management and functional leadership roles in global healthcare companies, with responsibility for full profit‑and‑loss management, product portfolios and business operations in regulated environments. His professional background spans general management, global marketing and sales as well as business and market development.

Prior to joining Sonova, he held senior leadership positions at Johnson & Johnson, Danaher and LivaNova. In these roles, his responsibilities included the management of global businesses and product lines, the commercialization of medical technologies, and the development of scalable operating models across regions. 

Alistair Simpson holds a Master of Business Administration from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh, USA, and a Bachelor of Science in Geography from the University of Glasgow, United Kingdom.

Outside mandates

Listed companies:

• n. a.

Other mandates:

• n. a.

Holdings as per 31.3.2025

• Shares¹⁾: –
• Performance Share Units: 605
• Options: 2’595

1) Shares are dividend entitled with full voting rights. For further details see also Note 7.4 in the consolidated financial statements.